347 related articles for article (PubMed ID: 15728227)
1. Nationwide survey on complementary and alternative medicine in cancer patients in Japan.
Hyodo I; Amano N; Eguchi K; Narabayashi M; Imanishi J; Hirai M; Nakano T; Takashima S
J Clin Oncol; 2005 Apr; 23(12):2645-54. PubMed ID: 15728227
[TBL] [Abstract][Full Text] [Related]
2. Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria.
Ezeome ER; Anarado AN
BMC Complement Altern Med; 2007 Sep; 7():28. PubMed ID: 17850665
[TBL] [Abstract][Full Text] [Related]
3. The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre.
Chrystal K; Allan S; Forgeson G; Isaacs R
N Z Med J; 2003 Jan; 116(1168):U296. PubMed ID: 12601420
[TBL] [Abstract][Full Text] [Related]
4. Perceptions and attitudes of clinical oncologists on complementary and alternative medicine: a nationwide survey in Japan.
Hyodo I; Eguchi K; Nishina T; Endo H; Tanimizu M; Mikami I; Takashima S; Imanishi J
Cancer; 2003 Jun; 97(11):2861-8. PubMed ID: 12767101
[TBL] [Abstract][Full Text] [Related]
5. Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death.
Rakovitch E; Pignol JP; Chartier C; Ezer M; Verma S; Dranitsaris G; Clemons M
Breast Cancer Res Treat; 2005 Mar; 90(2):139-48. PubMed ID: 15803360
[TBL] [Abstract][Full Text] [Related]
6. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer.
Singh H; Maskarinec G; Shumay DM
Integr Cancer Ther; 2005 Jun; 4(2):187-94. PubMed ID: 15911931
[TBL] [Abstract][Full Text] [Related]
7. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.
Eng J; Ramsum D; Verhoef M; Guns E; Davison J; Gallagher R
Integr Cancer Ther; 2003 Sep; 2(3):212-6. PubMed ID: 15035882
[TBL] [Abstract][Full Text] [Related]
8. Frequency of use of complementary and alternative medicine in women with breast cancer.
Lengacher CA; Bennett MP; Kip KE; Keller R; LaVance MS; Smith LS; Cox CE
Oncol Nurs Forum; 2002; 29(10):1445-52. PubMed ID: 12432415
[TBL] [Abstract][Full Text] [Related]
9. Patterns of the use of complementary and alternative medicine in women with metastatic cancer.
Yildirim Y
Cancer Nurs; 2010; 33(3):194-200. PubMed ID: 20357652
[TBL] [Abstract][Full Text] [Related]
10. The use of complementary and alternative medicine by cancer patients undergoing radiation therapy.
Swarup AB; Barrett W; Jazieh AR
Am J Clin Oncol; 2006 Oct; 29(5):468-73. PubMed ID: 17023781
[TBL] [Abstract][Full Text] [Related]
11. Complementary and alternative treatment methods in children with cancer: A population-based retrospective survey on the prevalence of use in Germany.
Laengler A; Spix C; Seifert G; Gottschling S; Graf N; Kaatsch P
Eur J Cancer; 2008 Oct; 44(15):2233-40. PubMed ID: 18809313
[TBL] [Abstract][Full Text] [Related]
12. Factors predicting the use of complementary and alternative therapies among cancer patients in Iran.
Montazeri A; Sajadian A; Ebrahimi M; Haghighat S; Harirchi I
Eur J Cancer Care (Engl); 2007 Mar; 16(2):144-9. PubMed ID: 17371423
[TBL] [Abstract][Full Text] [Related]
13. Quality of life and complementary and alternative medicine use among cancer patients in Turkey.
Can G; Erol O; Aydiner A; Topuz E
Eur J Oncol Nurs; 2009 Sep; 13(4):287-94. PubMed ID: 19395312
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer.
Pedersen CG; Christensen S; Jensen AB; Zachariae R
Eur J Cancer; 2009 Dec; 45(18):3172-81. PubMed ID: 19811905
[TBL] [Abstract][Full Text] [Related]
15. Complementary and alternative medicine use among colorectal cancer patients in Alberta, Canada.
Tough SC; Johnston DW; Verhoef MJ; Arthur K; Bryant H
Altern Ther Health Med; 2002; 8(2):54-6, 58-60, 62-4. PubMed ID: 11890386
[TBL] [Abstract][Full Text] [Related]
16. Design and testing of the use of a complementary and alternative therapies survey in women with breast cancer.
Lengacher CA; Bennett MP; Kipp KE; Berarducci A; Cox CE
Oncol Nurs Forum; 2003; 30(5):811-21. PubMed ID: 12949594
[TBL] [Abstract][Full Text] [Related]
17. Use of complementary medicinal therapies in West Pomerania: a population-based study.
Schwarz S; Messerschmidt H; Völzke H; Hoffmann W; Lucht M; Dören M
Climacteric; 2008 Apr; 11(2):124-34. PubMed ID: 18365855
[TBL] [Abstract][Full Text] [Related]
18. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.
Hlubocky FJ; Ratain MJ; Wen M; Daugherty CK
J Clin Oncol; 2007 Feb; 25(5):548-54. PubMed ID: 17290064
[TBL] [Abstract][Full Text] [Related]
19. Complementary and alternative medicine use in lung cancer patients in eight European countries.
Molassiotis A; Panteli V; Patiraki E; Ozden G; Platin N; Madsen E; Browall M; Fernandez-Ortega P; Pud D; Margulies A
Complement Ther Clin Pract; 2006 Feb; 12(1):34-9. PubMed ID: 16401528
[TBL] [Abstract][Full Text] [Related]
20. The use of complementary and alternative therapies by cancer patients in northern Israel.
Hana G; Bar-Sela G; Zhana D; Mashiach T; Robinson E
Isr Med Assoc J; 2005 Apr; 7(4):243-7. PubMed ID: 15847205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
